FDA Inspection 1208931 — Roswell Park Comprehensive Cancer Center IRB
The FDA completed an inspection of Roswell Park Comprehensive Cancer Center IRB on May 19, 2023 in Buffalo, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 19, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Buffalo, NY (United States)
Additional Details
IRB